Follow
Oncology Molecular Diagnostic
Clinical Oncology evaluations can include various molecular tests and the results can influence patient care. One example of an Oncology Molecular Diagnostic is mutation analysis for genes known to be confer a high risk of cancer such as BRCA1/2. Healthy patients found to carry this mutation benefit from increased screening and surveillance due to their increased risk of several cancers.
What's Popular in Oncology Molecular Diagnostic
-
NOV 10, 2023Clinical & Molecular DX
Globally, bladder cancer is the ninth most commonly diagnosed cancer and is the 13th leading cause of cancer-related dea ...Written By: Carmen LeitchOCT 24, 2023Technology
A team of researchers at the University Medical Center Utrecht and the Princess Máxima Center for pediatric oncol ...Written By: Ryan VingumOCT 11, 2023Clinical & Molecular DX
Tumors in the central nervous system are particularly deadly. During surgery to remove a brain tumor, surgeons usually h ...Written By: Carmen LeitchSEP 29, 2023Clinical & Molecular DX
The brain is a crucial, sensitive organ that is well-protected by the skull and blood brain barrier, which prevents many ...Written By: Carmen LeitchAUG 17, 2023Technology
A recent study published in Nature Machine Intelligence examines a novel deep-learning method known as BigMHC, which can ...Written By: Laurence Tognetti, MSc
NOV 10, 2023
Clinical & Molecular DX
Globally, bladder cancer is the ninth most commonly diagnosed cancer and is the 13th leading cause of cancer-related dea
...
Written By:
Carmen Leitch
OCT 24, 2023
Technology
A team of researchers at the University Medical Center Utrecht and the Princess Máxima Center for pediatric oncol
...
Written By:
Ryan Vingum
OCT 11, 2023
Clinical & Molecular DX
Tumors in the central nervous system are particularly deadly. During surgery to remove a brain tumor, surgeons usually h
...
Written By:
Carmen Leitch
SEP 29, 2023
Clinical & Molecular DX
The brain is a crucial, sensitive organ that is well-protected by the skull and blood brain barrier, which prevents many
...
Written By:
Carmen Leitch
AUG 17, 2023
Technology
A recent study published in Nature Machine Intelligence examines a novel deep-learning method known as BigMHC, which can
...
Written By:
Laurence Tognetti, MSc
JUN 27, 2023
Clinical & Molecular DX
Tuberculosis is still a major health problem in much of the world. It was the primary cause of death from an infectious
...
Written By:
Carmen Leitch
JUN 21, 2023
Genetics & Genomics
The Y chromosome is the smallest chromosome, and holds the least amount of genes, but scientists are still learning abou
...
Written By:
Carmen Leitch
JUN 15, 2023
Clinical & Molecular DX
When women have denser breasts than average, they may undergo mammograms to screen for breast cancer and be given a clea
...
Written By:
Carmen Leitch
JUN 02, 2023
Clinical & Molecular DX
Clinicians and researchers agree that it's best to treat cancer as soon as possible, which means an early diagnosis can
...
Written By:
Carmen Leitch
-
DEC 12, 2023 15:00 CET
The implementation of the new CE-In Vitro Diagnostics Regulation (IVDR) involves challenges faced by labs that are working within the diagnostic environment. The aim of this event is to get...Speaker: Dr. Bastiaan B.J. Tops , Dr. Etienne Rouleau , Dr. Javier Hernández Losa , Dr. Maria Scatolini , Jennifer Stobbs MRes.Presented at: Precision Medicine in Oncology
NOV 30, 2023 | 12:00 PM
Pathology Perspective: Discover the critical need for genomic testing in cancer and explore the differences between traditional tissue biopsies and liquid genomic profiling. We'll dive i...Speaker: Dr. Shuko Harada , Dr. Aakash Desai, MBBS, MPHPresented at: Precision Medicine in Solid Tumors
NOV 29, 2023 | 9:00 AM
Tumor genomic profiling can be complicated, especially for diseases that commonly have multiple different genomic biomarkers of interest, such as non-small cell lung cancer (NSCLC) and color...
NOV 16, 2023 | 8:00 AM
To bring your cutting-edge cell and gene therapies to the patients that need them as quickly as possible, you need access to the most knowledgeable scientists, innovative technologies, metho...
NOV 08, 2023 | 8:00 AM
SiO2 Materials Science is a company with deep roots in materials science and engineering and a track record of innovative packaging products for pharmaceutical drugs. The company also manufa...
DEC 12, 2023 15:00 CET
The implementation of the new CE-In Vitro Diagnostics Regulation (IVDR) involves challenges faced by labs that are working within the diagnostic environment. The aim of this event is to get...
Speaker:
Dr. Bastiaan B.J. Tops
, Dr. Etienne Rouleau
, Dr. Javier Hernández Losa
, Dr. Maria Scatolini
, Jennifer Stobbs MRes.
Presented at: Precision Medicine in Oncology
NOV 30, 2023 | 12:00 PM
Pathology Perspective: Discover the critical need for genomic testing in cancer and explore the differences between traditional tissue biopsies and liquid genomic profiling. We'll dive i...
Speaker:
Dr. Shuko Harada
, Dr. Aakash Desai, MBBS, MPH
Presented at: Precision Medicine in Solid Tumors
NOV 29, 2023 | 9:00 AM
Tumor genomic profiling can be complicated, especially for diseases that commonly have multiple different genomic biomarkers of interest, such as non-small cell lung cancer (NSCLC) and color...
NOV 16, 2023 | 8:00 AM
To bring your cutting-edge cell and gene therapies to the patients that need them as quickly as possible, you need access to the most knowledgeable scientists, innovative technologies, metho...
NOV 08, 2023 | 8:00 AM
SiO2 Materials Science is a company with deep roots in materials science and engineering and a track record of innovative packaging products for pharmaceutical drugs. The company also manufa...
OCT 30, 2023 | 8:00 PM
Description: Join this two-part webinar to learn how capillary electrophoresis (CE) complements sequencing technologies, such as next generation sequencing, that are being used by cancer res...
OCT 26, 2023 | 8:00 AM
Description: Join this two-part webinar to learn when capillary electrophoresis is an ideal choice relative to other various sequencing technologies – such as next generation sequencin...
OCT 24, 2023 | 8:00 AM
To bring your cutting-edge cell and gene therapies to the patients that need them as quickly as possible, you need access to the most knowledgeable scientists, innovative technologies, metho...
OCT 11, 2023 | 9:00 PM
Epigenetic modifications such as DNA methylation have long shown promise as potential biomarkers to diagnose and guide treatment of many human diseases, including multiple types of cancers....
Speaker:
Dr. Lucia Anna Muscarella, Ph.D.
, Dr. Cristina Guillén, Ph.D.
Sponsored By: Thermo Fisher Scientific
-
NOV 15, 2023C.E. CREDITS
Stago EdVantage Virtual University is an educational platform that demystifies hemostasis testing with on-demand webinars and a virtual exhibit hall that explore basic and compl...September 2023 - September 2024
The latest Diaceutics virtual event, “Precision medicine in oncology”, will allow you to join the forefront of cancer testing and treatment, with a series of 8 live webinars, cul...SEP 13, 2023 | 11:00 AM PDT
Liquid biopsy is an emerging area of clinical research, particularly in the context of cancer. As a minimally invasive complementary or alternative approach to tissue biopsies, liquid biopsi...NOV 30, 2023 | 10:00 AM PSTC.E. CREDITS
Precision medicine in solid tumors is transforming the testing and treatment of cancer. You can be part of this exciting field by joining our one-day virtual event. Some of the highlights of...JAN 31, 2023 | 8:00 AM PST
Empowering Multiplexing Innovation Luminex’s xMAP® Technology enables the evaluation of up to 500 analytes simultaneously in a single well, known as multiplexing. xMAP Technology u...
NOV 15, 2023
C.E. CREDITS
Stago EdVantage Virtual University is an educational platform that demystifies hemostasis testing with on-demand webinars and a virtual exhibit hall that explore basic and compl...
September 2023 - September 2024
The latest Diaceutics virtual event, “Precision medicine in oncology”, will allow you to join the forefront of cancer testing and treatment, with a series of 8 live webinars, cul...
SEP 13, 2023
| 11:00 AM PDT
Liquid biopsy is an emerging area of clinical research, particularly in the context of cancer. As a minimally invasive complementary or alternative approach to tissue biopsies, liquid biopsi...
NOV 30, 2023
| 10:00 AM PST
C.E. CREDITS
Precision medicine in solid tumors is transforming the testing and treatment of cancer. You can be part of this exciting field by joining our one-day virtual event. Some of the highlights of...
JAN 31, 2023
| 8:00 AM PST
Empowering Multiplexing Innovation Luminex’s xMAP® Technology enables the evaluation of up to 500 analytes simultaneously in a single well, known as multiplexing. xMAP Technology u...
NOV 09, 2022
| 5:30 AM PST
C.E. CREDITS
Labroots is pleased to host the 13th Annual Event in the Clinical Diagnostics and Research Virtual Event Series to be held on November 9th, 2022. Registration is open now....
OCT 19, 2022
| 5:30 AM PDT
C.E. CREDITS
Labroots announces the 2022 Coronavirus Virtual Event Series. A novel coronavirus emerged in China in 2019; it has since been dubbed COVID-19....
OCT 04, 2022
| 5:30 AM PDT
C.E. CREDITS
Labroots to host the 10th Annual Event in the Cancer Research & Immuno-Oncology Week Virtual Event Series! This two day event will take place on October 4-6, 2022....
JUN 22, 2022
| 3:00 AM PDT
Please join us for Ion World 2022, a virtual conference that will provide an opportunity to hear from scientists around the world, on how they are advancing research in a broad range of appl...